Skip to main content Skip to main navigation menu Skip to site footer
  • Register
  • Login
  • Menu
  • Home
  • Current
  • Archives
  • Announcements
  • About
    • About the Journal
    • Submissions
    • Editorial Team
    • Privacy Statement
    • Contact
  • Register
  • Login

Quality in Sport

Changes in the Treatment and Prevention of Heart Failure Based on the 2023 Focused Update of the 2021 European Society of Cardiology Guidelines
  • Home
  • /
  • Changes in the Treatment and Prevention of Heart Failure Based on the 2023 Focused Update of the 2021 European Society of Cardiology Guidelines
  1. Home /
  2. Archives /
  3. Vol. 24 (2024) /
  4. Medical Sciences

Changes in the Treatment and Prevention of Heart Failure Based on the 2023 Focused Update of the 2021 European Society of Cardiology Guidelines

Authors

  • Joanna Skotnicka Jerzy Popiełuszko Memorial Bielański Hospital, Warsaw, Poland, Cegłowska 80, 01-809 Warsaw, Poland https://orcid.org/0009-0008-7792-5817
  • Karolina Błaszczak Anna Gostynska Memorial Wolski Hospital, Warsaw, Poland, Marcina Kasprzaka 17, 01-211 Warsaw, Poland https://orcid.org/0009-0000-1534-6977
  • Maria Witkowska Jerzy Popiełuszko Memorial Bielański Hospital, Warsaw, Poland, Cegłowska 80, 01-809 Warsaw, Poland https://orcid.org/0009-0001-4019-938X
  • Monika Turek Warsaw Southern Hospital, Rotmistrza Witolda Pileckiego 99, 02-781 Warsaw, Poland https://orcid.org/0009-0008-4034-3346
  • Maciej Witkowski University Clinical Centre, Dębinki 7, 80-952 Gdańsk, Poland https://orcid.org/0009-0000-2386-2293
  • Tymoteusz Ślósarz Czerniakowski Hospital, Stępińska 19/25, 00-739 Warsaw, Poland https://orcid.org/0009-0007-4106-7729
  • Paulina Krupa Infant Jesus Clinical Hospital, Williama Heerleina Lindleya 4, 02-005 Warszawa https://orcid.org/0009-0003-4855-554X
  • Rafal Kaczorowski Medical University of Warsaw, Żwirki i Wigury 61, 02-091 Warsaw, Poland https://orcid.org/0009-0004-7042-114X
  • Tomasz Forenc Medical University of Warsaw, Żwirki i Wigury 61, 02-091 Warsaw, Poland https://orcid.org/0009-0007-9290-3571
  • Klara Wojciechowska Transfiguration of Lord Praski Hospital, aleja "Solidarności" 67, 03-401 Warsaw, Poland https://orcid.org/0009-0006-3370-7864

DOI:

https://doi.org/10.12775/QS.2024.24.54787

Keywords

Heart failure, Cardiovascular disease, heart diseases, Iron Deficiencies, Kidney Diseases

Abstract

Introduction and Objective:
The 2023 update to the 2021 ESC Guidelines for diagnosing and treating acute and chronic heart failure introduces significant changes in pharmacotherapy and prevention. Staying informed about these updates is crucial given the evolving landscape of heart failure management. This review provides an overview of the latest recommendations and supporting evidence.

Review Methods:
A comprehensive review of scientific publications and guidelines from PubMed, Google Scholar, Clinical Key, Via Medica Journals, and relevant clinical guidelines was conducted to ensure the most recent evidence is considered.

Brief Description of the State of Knowledge:
Heart failure is a growing global concern. The 2023 update highlights key management changes. Recent trials, including EMPEROR-Preserved and DELIVER, show empagliflozin and dapagliflozin reduce heart failure hospitalization and cardiovascular death in patients with mildly reduced and preserved ejection fraction. The guidelines now recommend intravenous iron for patients with reduced or mildly reduced ejection fraction and iron deficiency. For those with type 2 diabetes and chronic kidney disease, SGLT2 inhibitors and finerenone, a non-steroidal mineralocorticoid antagonist, are recommended to reduce heart failure hospitalization and prevent renal function decline.

Summary:
The 2023 ESC Guidelines update offers revised recommendations for heart failure management and prevention, integrating the latest clinical trial data and meta-analyses. Key areas include the use of SGLT2 inhibitors, iron deficiency management, and preventive strategies for high-risk populations. Implementing these guidelines can significantly improve preventive and therapeutic outcomes for heart failure patients.

References

Inamdar AA, Inamdar AC. Heart failure: Diagnosis, management and utilization. J Clin Med. 2016;5(7). doi:10.3390/jcm5070062

Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891-975. doi:10.1002/ejhf.592

Watson RD, Gibbs CR, Lip GY. ABC of heart failure. Clinical features and complications. BMJ. 2000;320(7229):236-239.

King M, Kingery J, Casey B. Diagnosis and evaluation of heart failure. Am Fam Physician. 2012;85(12):1161-1168.

Guha S, Harikrishnan S, Ray S, et al. CSI position statement on management of heart failure in India. Indian Heart J. 2018;70:S1-S72. doi:10.1016/j.ihj.2018.05.003

Ziaeian B, Fonarow GC. Epidemiology and aetiology of heart failure. Nat Rev Cardiol. 2016;13(6):368-378. doi:10.1038/nrcardio.2016.25

Groenewegen A, Rutten FH, Mosterd A, Hoes AW. Epidemiology of heart failure. Eur J Heart Fail. 2020;22(8):1342-1356. doi:10.1002/ejhf.1858

Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats AJS. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2022;118(17):3272-3287. doi:10.1093/cvr/cvac013

Golla MSG, Hajouli S, Ludhwani D. Heart Failure and Ejection Fraction. In: StatPearls. StatPearls Publishing; 2024.

Sapna F, Raveena F, Chandio M, et al. Advancements in Heart Failure Management: A Comprehensive Narrative Review of Emerging Therapies. Cureus. Published online October 4, 2023. doi:10.7759/cureus.46486

Malgie J, Clephas PRD, Brunner-La Rocca HP, de Boer RA, Brugts JJ. Guideline-directed medical therapy for HFrEF: sequencing strategies and barriers for life-saving drug therapy. Heart Fail Rev. 2023;28(5):1221-1234. doi:10.1007/s10741-023-10325-2

Herman LL, Padala SA, Ahmed I, Bashir K. Angiotensin-Converting Enzyme Inhibitors (ACEI). In: StatPearls. StatPearls Publishing; 2024.

Böhm M, Maack C. Treatment of heart failure with beta-blockers. Mechanisms and results. Basic Res Cardiol. 2000;95 Suppl 1:I15–24.

Jadhav U, Nair T, Mohanan P, et al. Impact of Mineralocorticoid Receptor Antagonists in the Treatment of Heart Failure: Targeting the Heart Failure Cascade. Cureus. Published online September 14, 2023. doi:10.7759/cureus.45241

Saeed MA, Narendran P. Dapagliflozin for the treatment of type 2 diabetes: A review of the literature. Drug Des Devel Ther. 2014;8:2493-2505. doi:10.2147/DDDT.S50963

Neumiller JJ. Empagliflozin: a new sodium-glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes. Drugs Context. 2014;3:212262.

McDonagh TA, Metra M, Adamo M, et al. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2023;44(37):3627-3639. doi:10.1093/eurheartj/ehad195

Fonseca-Correa JI, Correa-Rotter R. Sodium-Glucose Cotransporter 2 Inhibitors Mechanisms of Action: A Review. Front Med (Lausanne). 2021;8. doi:10.3389/fmed.2021.777861

Chao EC. SGLT-2 Inhibitors: A New Mechanism for Glycemic Control. Vol 32.; 2014.

Plodkowski RA, McGarvey ME, Huribal HM, et al. SGLT2 inhibitors for type 2 diabetes mellitus treatment. Fed Pract. 2015;32(Suppl 11):8S–15S.

Gupta R, Maitz T, Egeler D, et al. SGLT2 inhibitors in hypertension: Role beyond diabetes and heart failure. Trends Cardiovasc Med. 2022;33(8):479-486.

Al Rashid S, Elango P, Rahman SZ. SGLT2 Inhibitors for Cardioprotection. Oman Med J. 2023;38(4). doi:10.5001/omj.2023.128

McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-3726. doi:10.1093/eurheartj/ehab368

Singer CE, Vasile CM, Popescu M, et al. Role of Iron Deficiency in Heart Failure—Clinical and Treatment Approach: An Overview. Diagnostics. 2023;13(2). doi:10.3390/diagnostics13020304

Anand IS, Gupta P. Anemia and Iron Deficiency in Heart Failure: Current Concepts and Emerging Therapies. Circulation. 2018;138(1):80-98. doi:10.1161/CIRCULATIONAHA.118.030099

Lewis GD, Malhotra R, Hernandez AF, et al. Effect of Oral Iron Repletion on Exercise Capacity in Patients With Heart Failure With Reduced Ejection Fraction and Iron Deficiency: The IRONOUT HF Randomized Clinical Trial. JAMA. 2017;317(19):1958-1966. doi:10.1001/jama.2017.5427

Swedberg K, Young JB, Anand IS, et al. Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure. New England Journal of Medicine. 2013;368(13):1210-1219. doi:10.1056/nejmoa1214865

Swamy S, Noor SM, Mathew RO. Cardiovascular Disease in Diabetes and Chronic Kidney Disease. J Clin Med. 2023;12(22). doi:10.3390/jcm12226984

Masenga SK, Kirabo A. Hypertensive heart disease: risk factors, complications and mechanisms. Front Cardiovasc Med. 2023;10. doi:10.3389/fcvm.2023.1205475

Pei H, Wang W, Zhao D, Wang L, Su GH, Zhao Z. The use of a novel non-steroidal mineralocorticoid receptor antagonist finerenone for the treatment of chronic heart failure: A systematic review and meta-analysis. Medicine (United States). 2018;97(16). doi:10.1097/MD.0000000000010254

Downloads

  • PDF

Published

2024-10-07

How to Cite

1.
SKOTNICKA, Joanna, BŁASZCZAK, Karolina, WITKOWSKA, Maria, TUREK, Monika, WITKOWSKI, Maciej, ŚLÓSARZ, Tymoteusz, KRUPA, Paulina, KACZOROWSKI, Rafal, FORENC, Tomasz and WOJCIECHOWSKA, Klara. Changes in the Treatment and Prevention of Heart Failure Based on the 2023 Focused Update of the 2021 European Society of Cardiology Guidelines. Quality in Sport. Online. 7 October 2024. Vol. 24, p. 54787. [Accessed 6 July 2025]. DOI 10.12775/QS.2024.24.54787.
  • ISO 690
  • ACM
  • ACS
  • APA
  • ABNT
  • Chicago
  • Harvard
  • IEEE
  • MLA
  • Turabian
  • Vancouver
Download Citation
  • Endnote/Zotero/Mendeley (RIS)
  • BibTeX

Issue

Vol. 24 (2024)

Section

Medical Sciences

License

Copyright (c) 2024 Joanna Skotnicka, Karolina Błaszczak, 3. Maria Witkowska, Monika Turek, Maciej Witkowski, Tymoteusz Ślósarz, Paulina Krupa, Rafal Kaczorowski, Tomasz Forenc, Klara Wojciechowska

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Stats

Number of views and downloads: 146
Number of citations: 0

Search

Search

Browse

  • Browse Author Index
  • Issue archive

User

User

Current Issue

  • Atom logo
  • RSS2 logo
  • RSS1 logo

Information

  • For Readers
  • For Authors
  • For Librarians

Newsletter

Subscribe Unsubscribe

Tags

Search using one of provided tags:

Heart failure, Cardiovascular disease, heart diseases, Iron Deficiencies, Kidney Diseases
Up

Akademicka Platforma Czasopism

Najlepsze czasopisma naukowe i akademickie w jednym miejscu

apcz.umk.pl

Partners

  • Akademia Ignatianum w Krakowie
  • Akademickie Towarzystwo Andragogiczne
  • Fundacja Copernicus na rzecz Rozwoju Badań Naukowych
  • Instytut Historii im. Tadeusza Manteuffla Polskiej Akademii Nauk
  • Instytut Kultur Śródziemnomorskich i Orientalnych PAN
  • Instytut Tomistyczny
  • Karmelitański Instytut Duchowości w Krakowie
  • Ministerstwo Kultury i Dziedzictwa Narodowego
  • Państwowa Akademia Nauk Stosowanych w Krośnie
  • Państwowa Akademia Nauk Stosowanych we Włocławku
  • Państwowa Wyższa Szkoła Zawodowa im. Stanisława Pigonia w Krośnie
  • Polska Fundacja Przemysłu Kosmicznego
  • Polskie Towarzystwo Ekonomiczne
  • Polskie Towarzystwo Ludoznawcze
  • Towarzystwo Miłośników Torunia
  • Towarzystwo Naukowe w Toruniu
  • Uniwersytet im. Adama Mickiewicza w Poznaniu
  • Uniwersytet Komisji Edukacji Narodowej w Krakowie
  • Uniwersytet Mikołaja Kopernika
  • Uniwersytet w Białymstoku
  • Uniwersytet Warszawski
  • Wojewódzka Biblioteka Publiczna - Książnica Kopernikańska
  • Wyższe Seminarium Duchowne w Pelplinie / Wydawnictwo Diecezjalne „Bernardinum" w Pelplinie

© 2021- Nicolaus Copernicus University Accessibility statement Shop